Icosavax Moves Ahead with Potential Infectious Disease Vaccine

There’s a new player in the battle against viral disease. Icosavax, a new company launched under $51 million in investments led by Qiming Venture Partners USA, along with Sanofi Ventures, NanoDimension, and Adams Street Partners, is on its way to developing safe, effective vaccines to fight infectious diseases, address medical needs, and, ultimately, help reduce healthcare costs all around...